Nicotinamide and Skin Cancer: What the Research Really Says

A form of vitamin B3 called nicotinamide has been studied for its potential to lower the risk of certain skin cancers. Early lab work suggested it might help protect skin cells from damage, but real-world results haven’t been as clear. Some trials showed a small drop in cases of non-melanoma skin cancers, while others found no noticeable effect. The differences in these findings often come down to how the studies were designed or who participated. One major challenge is that most research focused on people already at high risk for skin cancer, like those with a history of sunburns or frequent sun exposure. But what about the average person? The studies don’t give a straightforward answer about whether nicotinamide would help someone with normal skin cancer odds. Another issue is dosage—how much should be taken, and for how long? The research used varying amounts, making it hard to pin down the best approach.

Even if nicotinamide shows some promise, it’s not a magic fix. Sunscreen and avoiding too much sun remain the best ways to prevent skin cancer. Nicotinamide might be an extra tool, but it shouldn’t replace proven methods. And like any supplement, it can have side effects, such as nausea or headaches, in some people. The debate isn’t just about whether nicotinamide works—it’s about how much the evidence actually supports its use. Some experts argue that the benefits are too small to justify widespread recommendations. Others believe more research could reveal clearer answers. Until then, people should stay cautious and not rely solely on supplements for protection.

Actions